EN
HI
Summary
As of 8 Nov, 2026, Natco Pharma stock price is ₹805.05. During the trading session, the stock has moved between an intraday low of ₹800.00 and an intraday high of ₹821.70. Over the last 52 weeks, Natco Pharma has traded between ₹773.60 and ₹1226.80.
The stock has recorded a trading volume of 1,29,689 shares,. Its Average Traded Price (ATP) is ₹808.94, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹805.05.
Natco Pharma has an upper circuit limit of ₹968.40 and a lower circuit limit of ₹645.60. The total value traded stands at ₹10.49 CR, and the delivery percentage for the day is 37.84%.
The stock is currently traded with a market lot size of 1. Natco Pharma also offers a dividend yield of 0.61%.
Natco Pharma Share Price Chart
Natco Pharma Share Key Metrics
Volume
1.30 L
Market Cap
15792.50 CR
LTQ@LTP
1@805.05
ATP
808.94
Var Margin
17.43 %
Circuit Range
645.6-968.4
Delivery %
37.84 %
Value
10.49 CR
ASM/GSM
No
Market Lot
1
Natco Pharma Fundamentals
P/E Ratio
13.84
P/B Ratio
1.49
Div. Yield
0.61
Sector P/E
40.24
Sector P/B
3.67
Sec. Div. Yield
0.52
Natco Pharma Resistance and Support
Pivot 807.73
Resistance
First Resistance
820.41
Second Resistance
833.83
Third Resistance
846.51
Support
First Support
794.31
Second Support
781.63
Third Support
768.21
Natco Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Sun Nov 08 2026 | 821.7 | 805.05 | -0.24% | 821.7 | 800 |
| Fri Nov 06 2026 | 799 | 807 | 1.31% | 821.15 | 795.04 |
| Thu Nov 05 2026 | 797 | 796.59 | 0.99% | 809.9 | 789.65 |
Natco Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-13 | Quarterly Results & Interim Dividend |
| 2026-09-25 | Rights issue of Equity Shares |
| 2026-09-09 | Fund Raising |
| 2026-08-14 | Quarterly Results & Interim Dividend |
| 2026-05-29 | Audited Results |
| 2026-03-24 | Scheme of Arrangement |
| 2026-02-12 | Quarterly Results & Interim Dividend |
| 2025-11-14 | Quarterly Results & Interim Dividend |
| 2025-08-12 | Quarterly Results & Interim Dividend |
| 2025-05-28 | Audited Results |
| 2025-02-12 | Quarterly Results & Interim Dividend |
| 2024-11-12 | Quarterly Results & Interim Dividend |
| 2024-08-12 | Quarterly Results & Interim Dividend |
Natco Pharma News
Natco Pharma Ltd - 524816 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
Promoter V.C. Nannapaneni created a pledge on 8.5 lakh shares, representing 0.47% of the total share capital. The pledge is in favor of Bajaj Financial Securities for subscribing to the rights issue.
Nov 04 2026 15:31:16
Natco Pharma Ltd - 524816 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Natco Pharma promoters acquired 22.11 lakh shares worth Rs.165.88 crores through a rights issue allotment on 26 Oct 2026. Major acquirers include Time Cap Pharma Labs (9.33 lakh shares) and Venkaiah Chowdary Nannapaneni (5.86 lakh shares).
Oct 30 2026 10:42:53
Read More
Natco Pharma Management
| Name | Position |
|---|---|
| Chekuri Venkat Ramesh | Company Secretary & Compliance Officer |
| V C Nannapaneni | Chairman & Managing Director |
Natco Pharma Similar Stocks
Cohance Lifesciences Ltd.
442.00
8.45 (1.95%)
Eris Lifesciences Ltd.
1252.70
18.60 (1.51%)
Dr. Agarwal's Health Care Ltd.
514.60
-1.75 (0.34%)
Poly Medicure Ltd.
1598.40
-13.90 (0.86%)
Molbio Diagnostics Ltd.
1360.20
20.90 (1.56%)
Jubilant Pharmova Ltd.
942.95
3.35 (0.36%)
Vijaya Diagnostic Centre Ltd.
1466.60
-2.00 (0.14%)
CORONA Remedies Ltd.
2534.20
93.10 (3.81%)
Marksans Pharma Ltd.
303.75
0.05 (0.02%)
Concord Biotech Ltd.
612.20
-20.40 (3.22%)
Natco Pharma FAQs
The Buying Price of Natco Pharma share is 805.05 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Natco Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Natco Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Natco Pharma shares is 13.84. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Natco Pharma shares is 1.49. Useful to assess the stock's value relative to its book value.
To assess Natco Pharma’s valuation compare Sector P/E, P/B which are 40.24 & 3.67 with sector averages, along with growth rates and financial metrics.
The Market Cap of Natco Pharma is 15792.50 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Natco Pharma share price is 1226.80 & 773.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Natco Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in NATCOPHARM
Or Download Choice FinX App
Invest in NATCOPHARM
